System-level Tobacco Treatment Intervention for Smoking Cessation

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byMary E Cooley, PhD, RN

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Dana-Farber Cancer Institute

No Placebo Group

Trial Summary

What is the purpose of this trial?

The proposed study plans to adapt and study the implementation and effectiveness of integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the thoracic oncology setting using mixed methods.

Eligibility Criteria

This trial is for current or recent smokers (within the last 6 months) who are over 18, can read and write in English, and have or might have lung-related cancer. It's not for those who quit smoking more than 6 months ago or have urgent health issues like severe breathing problems, very low blood pressure, confusion from high calcium levels, or dehydration.

Inclusion Criteria

Able to read and write in English.

You have smoked within the past 6 months.

I have an active phone number.

See 2 more

Exclusion Criteria

I am experiencing severe breathing difficulties.

I am not dehydrated.

I quit smoking more than 6 months ago.

See 3 more

Treatment Details

Interventions

CEASE (Behavioural Intervention)
Usual Care Tobacco Treatment Services (Behavioural Intervention)

Trial OverviewThe study is testing how well a program called CEASE works when it's added to usual care that helps people stop smoking in a lung cancer treatment setting. Researchers will use different methods to see how effective this integration is compared to the standard support services.

Participant Groups

5Treatment groups

Experimental Treatment

Active Control

Group I: After Cease Implementation Aim 2Experimental Treatment1 Intervention

50 Current or former smokers (3 months +/-2 month) * Tobacco Use Survey (Baseline,1- 6 Months) * Biochemical verification

Group II: Cease-Aim 1Active Control1 Intervention

* Cease Implementation * 100 Patients after CEASE Implementation * Exit Interview and Tobacco Use Survey

Group III: Pre Cease Implementation Aim 2Active Control1 Intervention

50 Current or former smokers (3 months +/-2 month) patients in usual care (before CEASE implementation) * Tobacco Use Survey (Baseline,1- 6 Months) * Biochemical verification

Group IV: Usual Care-Aim 1Active Control1 Intervention

Usual Care Tobacco Treatment Services * 100 patients in usual care * Exit Interview and Tobacco Use Survey

Group V: Clinician and Staff SurveyActive Control1 Intervention

- Interview clinicians and support staff (40)